We are live on ! Find out more
BP

BCK Partners Portfolio holdings

AUM $207M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+18%
3 Year Est. Return
+44.58%
5 Year Est. Return
+37.67%
10 Year Est. Return
AUM
$160M
AUM Growth
+$6.11M
Cap. Flow
+$506K
Cap. Flow %
0.32%
Top 10 Hldgs %
95.18%
Holding
28
New
Increased
7
Reduced
15
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$403B
-1,938
Closed -$238K
AMGN icon
27
Amgen
AMGN
$208B
-1,042
Closed -$252K
TMO icon
28
Thermo Fisher Scientific
TMO
$213B
-414
Closed -$239K

Similar funds

BCK Partners's Q2 2023 Portfolio in Review

As of Q2 2023, BCK Partners held 28 positions worth $160M, up 4% from $154M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

BCK Partners's Q2 2023 filing shows 7 increased, 15 reduced and 3 closed positions. The largest sale was Vanguard S&P 500 ETF, an estimated $1.63M.

By sector, the portfolio is most concentrated in Technology at 1.3% of assets, down from 1.5% a quarter earlier, followed by Financials and Healthcare.

  • BCK Partners added most to Vanguard Short-Term Corporate Bond ETF in Q2 2023, an estimated $3.74M increase.
  • BCK Partners's biggest Q2 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.63M.
  • BCK Partners fully exited Amgen in Q2 2023, selling an estimated $252K.
  • BCK Partners's ten largest holdings make up 95% of its $160M portfolio in Q2 2023.
  • BCK Partners opened 0 new positions and closed 3 in Q2 2023.
  • BCK Partners's portfolio value rose 4% quarter-over-quarter to $160M.

Based on BCK Partners's 13F filing for Q2 2023, filed 20 Jul 2023.